Arkolith/Insider Trading/VIRX/Form 4

Rothera Mark

President and CEO, DirectorViracta Therapeutics, Inc. (VIRX) · full profile →Form 4 · filed Dec 4, 2023
Net Buying
Open-Market Buys
$49K
Open-Market Sells
$0
Net Open-Market Flow
$49K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 1, 2023Buy(P)48K$0.49$23K100K
Nov 30, 2023Buy(P)52K$0.49$26K52K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-057239) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML